Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
•
Interventional Cardiology
What has been your experience with Coronary CTA with FFR results and its ability to accurately predict epicardial CAD on diagnostic LHC?
Related Questions
What has been your approach to percutaneous intervention for calcified nodules and threshold for intervention?
Is there any difference between colchicine 0.5mg vs 0.6 mg for high risk coronary artery disease?
Do you prefer the routine use of bivalirudin over UFH during PCI cases in patients presenting with ACS?
Would you defer or opt for plavix loading in a patient already on DAPT presenting with NSTEMI attributed to non-ischemic myocardial injury but with known CAD?
What is your preferred duration for triple therapy post-PCI in patients on systemic anticoagulation?
Do you recommend stepwise de-escalation of dual antiplatelet therapy for patients at high risk of bleeding who have undergone drug-coated balloon angioplasty?
What has been your approach to minimizing the risk of vascular complications when placing Impella support devices?
How do you manage anticoagulation/antiplatelet therapies with strong indications for uninterrupted therapy in setting of urgent procedures?
For patients presenting with suspected type 1 NSTEMI and atrial fibrillation on anticoagulation, do you favor triple therapy or SAPT with systemic anticoagulation instead while awaiting LHC?
What is your stepwise approach to managing no re-flow during PCI?
